RA
EVH icon

Royce & Associates’s Evolent Health EVH Stock Holding History

Royce & Associates’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-663,010
Closed -$7.47M – 788
2025
Q2 		$7.47M Buy
663,010
+92,130
+16% +$846K 0.08% 372
2025
Q1 		$5.41M Sell
570,880
-5,320
-0.9% -$53.7K 0.06% 432
2024
Q4 		$6.48M Buy
576,200
+326,200
+130% +$5.73M 0.06% 427
2024
Q3 		$7.07M Buy
+250,000
New +$6.44M 0.06% 407
2021
Q4 		– Sell
-310,036
Closed -$9.61M – 979
2021
Q3 		$9.61M Sell
310,036
-105,775
-25% -$2.54M 0.07% 423
2021
Q2 		$8.78M Sell
415,811
-57,500
-12% -$1.15M 0.06% 460
2021
Q1 		$9.56M Sell
473,311
-94,000
-17% -$1.79M 0.06% 456
2020
Q4 		$9.09M Sell
567,311
-91,000
-14% -$1.2M 0.08% 397
2020
Q3 		$8.17M Sell
658,311
-67,500
-9% -$794K 0.09% 339
2020
Q2 		$5.17M Buy
725,811
+192,400
+36% +$1.29M 0.06% 447
2020
Q1 		$2.9M Buy
533,411
+62,000
+13% +$554K 0.04% 509
2019
Q4 		$4.27M Sell
471,411
-521,000
-52% -$4.23M 0.04% 529
2019
Q3 		$7.13M Buy
992,411
+265,811
+37% +$1.91M 0.07% 389
2019
Q2 		$5.78M Buy
726,600
+305,000
+72% +$3.61M 0.05% 458
2019
Q1 		$5.3M Buy
421,600
+315,600
+298% +$5M 0.04% 494
2018
Q4 		$2.12M Buy
+106,000
New +$2.45M 0.02% 716

Other funds holding EVH

CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Royce & Associates's EVH Position: Q3 2025 in Review

Royce & Associates sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 663,010 shares — an estimated $7.47M sold.

Royce & Associates first reported a position in EVH in Q4 2018 and held it in 16 quarters. The position peaked at $9.61M in Q3 2021. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Royce & Associates reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • Royce & Associates sold 663,010 Evolent Health shares in Q3 2025, an estimated $7.47M.
  • Royce & Associates first reported a position in Evolent Health in Q4 2018 and held it in 16 quarters.
  • Royce & Associates's Evolent Health position peaked at $9.61M in Q3 2021.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Royce & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.